AYAkio Yanagisawa

Akio Yanagisawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Akio Yanagisawa has a total of 117 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Are Biopsy Specimens Effective for Evaluating HER2 Expression in Extrahepatic Bile Duct and Gallbladder Cancer?

    by Osamu Inamori, Akio Yanagisawa, Yoko Hino, Yoji Urata

    Biliary tract cancer has a poor prognosis, with systemic chemotherapies showing limited benefit. New therapeutic targets are urgently needed to improve the prognosis of biliary tract cancer. Since HER2-targeted therapies have shown promising results for biliary tract cancer, accurate assessment for HER2 status in biopsy samples, which are often the only diagnostic material available for inoperable lesions, is crucial. This study assessed HER2 expression in 108 samples (surgical specimens and biopsies) from 84 biliary tract cancer patients. HER2 IHC scores of 2+ (equivocal) and 3+ (overexpression) were observed in 11% (7/65 specimens) and 9% (6/65 specimens) of biopsy specimens, and 7% (3/43 specimens) and 7% (3/43 specimens) of surgical specimens, respectively. The HER2 concordance rate between matched biopsy and surgical specimens was 75%. The results suggest that HER2 assessment in biopsies may reliably predict HER2 status across the tumor, supporting treatment decisions. However, the study acknowledges certain limitations, including the need for additional in situ hybridization tests in lesions of ambiguous HER2 overexpression. In conclusion, the HER2 status on biopsy specimens may reflect the HER2 status of the whole lesion and could be used to select suitable patients for neoadjuvant HER2-targeted therapy.

  • Is preoperative pancreatic juice cytology useful for determining therapeutic strategies for patients with intraductal papillary mucinous neoplasm of the pancreas?

    by Rintaro Nagayama, Toshiharu Ueki, Yasuhiro Shimizu, Susumu Hijioka, Masafumi Nakamura, Masayuki Kitano, Kazuo Hara, Atsushi Masamune, Toshifumi Kin, Keiji Hanada, et al.

    Background: We compared the results of preoperative pancreatic juice cytology (PJC) and final pathological diagnosis after resection in patients who underwent resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas to determine whether preoperative PJC can help determine therapeutic strategies.Methods: Of 1130 patients who underwent surgical resection IPMN at 11 Japanese tertiary institutions, the study included 852 patients who underwent preoperative PJC guided by endoscopic retrograde cholangiopancreatography (ERCP).Results: The accuracy of preoperative PJC for differentiation between cancerous and noncancerous lesions were 55% for IPMN overall; 59% for the branch duct type; 49% for the main pancreatic duct type; 53% for the mixed type, respectively. On classifying IPMN according to the diameters of the mural nodule (MN) and main pancreatic duct (MPD), the corresponding values for diagnostic performance were 40% for type 1 (MN >= 5 mm and MPD >= 10 mm); 46% for type 2 (MN >= 5 mm and MPD < 10 mm); 61% for type 3 (MN < 5 mm and MPD >= 10 mm); 72% for type 4 (MN < 5 mm and MPD < 10 mm), respectively.Conclusions: PJC in IPMN is not a recommended examination because of its low overall sensitivity and no significant difference in diagnostic performance by type, location, or subclassification. Although the sensitivity is low, the positive predictive value is high, so we suggest that pancreatic juice cytology be performed only in cases where the patient is not sure about surgery.


  • Open Access

    A case of hepatic anisakidosis caused by Anisakis pegreffii mimicking liver cancer

    by Minoru Yamada, Fumi Murakoshi, Hisashi Ikoma, Osamu Inamori, Akio Yanagisawa, Eiichi Konishi

    Extra-gastrointestinal anisakidosis is rare. We herein report an Anisakis pegreffii infection in a patient with hepatic anisakidosis diagnosed based on its molecular identification. A 71-year-old male patient had a hepatic tumor presenting as a low-density area of 20 mm in diameter in segment 6 of the liver on abdominal ultrasonography, computed tomography, and magnetic resonance imaging. The surgically resected pathological specimen revealed a necrotizing eosinophilic granuloma containing nematode larvae, possibly an Anisakis larva. Molecular and phylogenetic analysis demonstrated Anisakis larvae belonging to A. pegreffii. The present results will help identify and characterize unknown Anisakis species in histological sections.


  • Surgical indication for intraductal papillary mucinous neoplasm without mural nodule ≥5 mm

    by Ayako Tsumura, Seiko Hirono, Manabu Kawai, Ken-Ichi Okada, Motoki Miyazawa, Yuji Kitahata, Ryohei Kobayashi, Shinya Hayami, Masaki Ueno, Akio Yanagisawa, et al.


  • Open Access

    Mucinous Cystadenocarcinoma Arising in the Mesentery Proper—A Case Report—

    by Shoji Hirajima, Tsuyoshi Takagi, Hiroki Kobayashi, Kanehisa Fukumoto, Akio Yanagisawa

    症例は63歳,男性.上部直腸癌精査時のCTで,腸間膜に長径70mm大の不整形,内部に石灰化を伴い造影効果のある嚢胞性腫瘤を認めた.リンパ管腫,GISTを鑑別診断として,直腸癌手術と同時に嚢腫摘出術を施行した.嚢腫は終末回腸から130cm口側の小腸間膜に不整形の腫瘤として存在し,小腸との連続性は認めなかった.小腸間膜の血管を温存する格好で,完全切除は容易であった.摘出した嚢腫は80mm×45mm×25mmで,内部には黄色の粘液性物質と透明の漿液性物質が混在していた.病理検査で嚢腫壁に粘液を有する円柱上皮を認め,腸間膜粘液性嚢胞腺癌と診断された.腸間膜嚢腫は比較的まれな疾患であり,嚢腫に悪性所見を伴うことは極めてまれである.われわれは上部直腸癌術前に偶然発見された無症候性小腸腸間膜粘液性嚢胞腺癌を経験したので報告する.


  • A NOXA/MCL‐1 Imbalance Underlies Chemoresistance of Malignant Rhabdoid Tumor Cells

    by Kazutaka Ouchi, Yasumichi Kuwahara, Tomoko Iehara, Mitsuru Miyachi, Yoshiki Katsumi, Kunihiko Tsuchiya, Eiichi Konishi, Akio Yanagisawa, Hajime Hosoi

    Malignant rhabdoid tumor (MRT) is a rare aggressive pediatric cancer characterized by inactivation of SNF5, a core subunit of SWI/SNF complexes. Previously, we showed that SNF5 contributes to transcriptional activation of NOXA, a pro‐apoptotic protein that binds and inhibits the anti‐apoptotic protein MCL‐1. In this study, we found that NOXA expression was downregulated in MRT cell lines as well as in clinical MRT samples and that ectopically expressed NOXA bound MCL‐1 and increased the sensitivity of MRT cell lines to doxorubicin (DOX) by promoting apoptosis. Consistent with this finding, knockdown of MCL‐1 in MRT cell lines induced apoptosis and increased DOX sensitivity in MRT cells, and the MCL‐1 inhibitor TW‐37 synergized with DOX to induce MRT cell death. Our results suggest that modulation of the NOXA/MCL‐1 pathway may be a potential strategy for the treatment of patients with MRT. J. Cell. Physiol. 231: 1932–1940, 2016.


  • 98 Prospective Multicenter Randomized Controlled Trial of Histological Diagnostic Yield Comparing 25G EUS-FNA Needles With and Without a Core Trap in Patients With Solid Pancreatic Masses

    by Reiko Ashida, Satoru Yasukawa, Akio Yanagisawa, Ken Kamata, Masatoshi Kudo, Takeshi Ogura, Kazuhide Higuchi, Nobuyasu Fukutake, Hiroko Nebiki, Satoru Hirose, et al.


  • Pancreatogram Findings for Carcinoma in situ (CIS) of the Pancreas Seen on Endoscopic Retrograde Cholangiopancreatography and Postoperative Pancreatography of Resected Specimens: Can CIS Be Diagnosed Preoperatively?

    by Makoto Seki, Eiji Ninomiya, Koichi Takano, Rikiya Fujita, Akiko Aruga, Keiko Yamada, Hiroko Tanaka, Kiyoshi Matsueda, Kazuhisa Mikami, Naoki Hiki, et al.

    From 1992 to 2003, 7 carcinomata in situ (CIS) were incidentally discovered during microscopical observation of resected materials for advanced carcinomas of peripancreatic organs, of which 4 had undergone endoscopic retrograde cholangiopancreatography (ERCP) or postoperative pancreatography of the resected specimen (POP). In addition, 7 of 79 invasive ductal carcinomata (IDC) of the pancreas were accompanied by CIS > or =2 cm long. A total of 11 patients were reviewed here for pancreatographic findings for CIS of the pancreas. All resected pancreatobiliary materials were sliced serially at 5- to 8-mm intervals in a plane at right angles to the main pancreatic duct, referring to POP images. Irregularity (I), non-continuous narrowing (N), granular defects (G), and dilatation (D) were seen in 78, 67, 33 and 22% on ERCP, respectively, and in 90, 70, 60 and 40% on POP, respectively. I, N, G, and D are most important pancreatographic findings in ERCP and highly suggestive of CIS of the pancreas, so that whenever they are encountered, cytological and/or pathological examination of the pancreatic duct should be actively performed.


  • Pancreatic endocrine tumor with partial acinar cell differentiation

    by Kyoko Minakawa, Kuniyuki Oka, Takeshi Nihei, Norimasa Sando, Haruna Oikawa, Joe Toda, Yoshinori Hosokawa, Toshiharu Matsumoto, Akio Yanagisawa

    We examined a 70‐year‐old woman in whom a pancreatic endocrine tumor with partial acinar cell differentiation had been diagnosed. She had neither endocrine nor exocrine symptoms. The tumor was located in the pancreatic tail and measured 12.5×9.5×8 cm. It had a capsule, was composed of multiple adhesion nodules, and was elastically soft, medullary, and yellowish white. The neoplastic cells had large, irregular, oval nuclei; prominent eosinophilic nucleoli; and abundant eosinophilic cytoplasm with many fine granules. The cells had proliferated in islet‐like solid medullary, trabecular, acinar, and papillary patterns. Most neoplastic cells were strongly positive for synaptophysin. 10 to 25% of the neoplastic cells were positive for α1‐antitrypsin. Neuroendocrine and zymogen granules were simultaneously observed in the cytoplasm of the same neoplastic cells at the ultrastructural level. The tumor may be considered an amphicrine tumor.


  • Cytogenetic and clinicopathological characterization by fluorescencein situhybridization on paraffin-embedded tissue sections of twenty-six cases with malignant lymphoma of small intestine

    by Naohisa Yoshida, Kenichi Nomura, Naoki Wakabayashi, Hideyuki Konishi, Kazuhiro Nishida, Tomohiko Taki, Shoji Mitsufuji, Shigeo Horiike, Akio Yanagisawa, Hisakazu Yamagishi, et al.

    In small intestinal malignant lymphoma (SIML), the correlation between specific chromosomal abnormalities and clinicopathological features remains unclear. The aim of this study was to determine the frequency of chromosomal translocations involving the BCL1, BCL2, c-MYC, BCL6 and MALT1 genes by using fluorescence in situ hybridization directly on paraffin-embedded tissue sections (tissue-FISH). Twenty-six cases diagnosed as having SIML between 1996 and 2003 were the subjects of the clinicopathological investigation conducted in this study. Tissue-FISH was performed with specific probes on paraffin-embedded tissue sections as described previously. The primary site was frequently located at the duodenum (9 cases, 35%). In accordance with the World Health Organization classification, 14 (53%) cases were diagnosed as having diffuse large B-cell lymphoma (DLBCL) and 6 (23%) as marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT). Macroscopically, DLBCL and MALT lymphoma displayed various macroscopic features. Cytogenetically, IGH-BCL2 translocation was detected in 3 (21%) out of 14 DLBCL cases, but in none of the MALT lymphomas. BCL6 translocation was detected in 5 (35%) of 14 DLBCL cases and in 1 (17%) of 6 MALT lymphoma cases (17%). API2-MALT1 translocation was detected in 1 (7%) of 14 DLBCL cases and in 1 (17%) of 6 MALT lymphoma cases. The duodenum was preferentially involved in SIML. DLBCL and MALT lymphoma showed various macroscopic features. Tissue-FISH analysis disclosed that DLBCL is cytogenetically heterogeneous. Furthermore, our study validated tissue-FISH as an additional promising diagnostic tool for detecting specific chromosomal translocations in NHL.